CAD 19
Age-related macular degeneration and diabetic retinopathy.
Monotherapy and combination treatment with other intravitreal injection drugs.
Reduces the medical burden, provides convenience, and prevents disease progression and new pathological changes in patients.
Pre-clinical trials.
